Premium
Dopamine receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor
Author(s) -
GarcíaMartín Elena,
Martínez Carmen,
AlonsoNavarro Hortensia,
BenitoLeón Julián,
Puertas Inmaculada,
Rubio Lluisa,
LópezAlburquerque Tomás,
Agúndez José A. G.,
JiménezJiménez Félix Javier
Publication year - 2009
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.22518
Subject(s) - dopamine receptor d3 , allele , genotype , essential tremor , dopamine receptor , dopamine receptor d2 , dopamine , genetics , biology , neuroscience , medicine , gene
To investigate the possible association between dopamine receptor D3 genotype ( DRD3 ) and allelic variants and the risk for developing essential tremor (ET). Leukocytary DNA from 201 patients with ET and 282 healthy controls was studied for the genotype DRD3 and the occurrence of DRD3 allelic variants by using allele‐specific PCR amplification and Msl I‐RFLP's analyses. A meta‐analysis of previous studies was performed. The frequencies of the DRD3Ser/Gly genotype and of the allelic variant DRDGly were significantly higher in patients with ET than in controls ( P < 0.017 and <0.005, respectively), These findings were especially relevant in women (OR = 1.73, 95% CI: 1.15–2.59, P = 0.008), and in patients with earlier onset of the disease with ( P = 0.014). The frequencies of the DRD3Ser/Gly and DRD3Gly/Gly genotypes and of the allelic variant DRD3Gly in patients were significantly higher in patients with voice tremor, but not with head, tongue, or chin tremor, than in controls. The meta‐analysis indicated association of variant genotypes with ET risk (OR = 1.18, 95% CI 1.01–1.38). These results suggest that DRD3 genotype and the variant DRD3Gly allelic variant is associated with the risk for and age at onset of ET, and with the risk for voice tremor, in Caucasian Spanish people. © 2009 Movement Disorder Society